FEVAR - search results
If you're not happy with the results, please do another search
Design of “first” trial comparing ESAR and FEVAR in short neck patients revealed at...
Sharing first-time data from the SOCRATES (ShOrt neCK AAA RAndomized Trial) design, Giovanni Torsello (St Franziskus Hospital, Münster, Germany) expanded on the intentions of...
Three-year data bolster use of the BeGraft as a bridging stent in FEVAR
This advertorial is sponsored by Bentley.
Stéphan Haulon (Hôpital Marie Lannelongue, GHPSJ, Paris, France) has extensive clinical experience using the BeGraft (Bentley, Hechingen, Germany) as a...
Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent
Bentley has announced that recruitment is now complete in the fenestrated endovascular aortic aneurysm repair (FEVAR) study that uses the company's BeGraft peripheral balloon-expandable...
Recruitment passes halfway point for FEVAR study with Bentley bridging stent
Bentley has announced that on-label use of the company's BeGraft peripheral balloon-expandable covered stent in complex aortic aneurysms is a step closer with more...
BUTTERFLY study finds most reinterventions after FEVAR are not related to balloon-expandable covered stent...
A mid-term assessment of bridging stentgraft integrity and flare geometry following fenestrated endovascular aortic repair (FEVAR) finds that, although there is a substantial reintervention...
First patient treated in the BeGraft FEVAR study aimed at providing evidence for on-label...
On 19 March, the first patient was included in the BeGraft fenestrated endovascular aneurysm repair (FEVAR) study investigating the Bentley BeGraft peripheral balloon expandable...
Multicentre, physician-initiated study set to provide key data on bridging stents in FEVAR
This advertorial is sponsored by Bentley.
There are numerous covered stents on the market that are used as bridging stents in fenestrated endovascular aneurysm repair...
“From pioneering times to a mature technology”: The evolution of bridging stents for FEVAR...
There are several covered stents on the market that are used in an off-label setting as bridging stents for fenestrated and branched endovascular aneurysm...
Aortic neck dilation after FEVAR leads to little clinical impact, new mid-term study data...
Data, gathered in a study on the impact of aortic neck dilation after fenestrated endovascular aortic aneurysm repair (FEVAR), show that the process does...
Aortic neck dilation “never exceeds device diameter” during FEVAR follow-up
Following a fenestrated endovascular aneurysm repair (FEVAR), the infrarenal aortic neck often continues to dilate. At the 2017 VEITHsymposium, Benjamin Starnes (University of Washington,...
Successful results for Aortica’s AortaFit FEVAR planning software
Benjamin Starnes, chief of Vascular Surgery at the University of Washington (Seattle, USA), has reported successful results for the first 30 patients undergoing fenestrated...
Midterm FEVAR physician-sponsored IDE data “excellent”
Benjamin W Starnes, chief of Vascular Surgery at the University of Washington, USA, and one of the world’s foremost authorities on the treatment of...
Automated planning software could lead to wider FEVAR adoption
While the long-term durability of fenestrated endovascular repair (FEVAR) has been established, the need for accurate procedural planning may act as a barrier to...
First simplified FEVAR procedure using AortaFit and Bolton Treo performed
Aortica Corporation has announced that Benjamin Starnes, chief of Vascular Surgery at the University of Washington, completed the first three-vessel fenestrated endovascular aneurysm repair...
Complex triple or quadruple FEVAR does not increase perioperative mortality or morbidity compared with...
At the Vascular Annual Meeting (9–11 June, National Harbor, USA), data were presented suggesting that complex triple or quadruple fenestrated endovascular aneurysm repair (FEVAR)...
Early follow-up of FEVAR/BEVAR using supra-coeliac sealing zones and four-vessel designs shows no mortality...
Fenestrated and branched endovascular aneurysm repair (FEVAR/BEVAR) using supra-coeliac sealing zones and four-vessel designs is safe can be performed with “excellent” early outcomes according...
First US patient enrolled in SOCRATES short neck AAA trial
The first US patient has been treated as part of the SOCRATES trial (Short neck AAA randomised trial—ESAR and FEVAR), which compares the safety...
US FDA approves study of ZFEN+ for the treatment of aortic aneurysms
The US Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Zenith...
“Vigilant” surveillance and low threshold for further interventions “crucial” following rescue of prior EVAR...
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index...
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical.
Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those...
Short neck AAAs: “Choosing what is best for the patient”
Navigating cases of abdominal aortic aneurysm (AAA) with short neck anatomy pose a serious challenge to vascular surgeons, but the list of potential options...
UK-COMPASS maps out complex aneurysm treatment in England, points to possible overtreatment
Data from the UK-COMPASS trial provide new insights into the management of complex aneurysm treatment in England and, according to lead investigator Srinivasa Rao...
CX Aortic Vienna: New technologies continue to expand vascular surgery armamentarium
From parallel grafting to the role of hybrid operating rooms, the importance of vascular surgeons having a wide range of devices and options at...
Pararenal and juxtarenal aortic aneurysms under the microscope in HTDI session at CX Aortic...
State-of-the-art open and endovascular techniques for the treatment of pararenal and juxtarenal aortic aneurysms were put under the microscope of the specialist aortic team...
CX Aortic Vienna: Sac diameter increase must be monitored and investigated
There was consensus on day one of the CX Aortic Vienna 2022 Digital Edition (24–26 October) that aortic sac regression is a positive sign...
Demand for “widely applicable” inner branch technology set to increase as evidence builds
NOTE: This video is ONLY available to watch in selected countries and geographies
Said Abisi (London, UK) discusses inner branched endovascular aneurysm repair (iBEVAR)...
Vascular News’ top 10 most popular stories of July 2022
July's top 10 most popular items include more from this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2022; 15–18 June, Boston,...
Alexander Zimmermann
Alexander Zimmermann (University Hospital Zurich, Zurich, Switzerland) tells Vascular News about his career to date, beginning with a rotation in vascular surgery that opened...
Investigator-initiated studies pave the way for on-label bridging stent use in complex aortic procedures
This advertorial is sponsored by Bentley.
Bridging stents have been used in fenestrated and branched endovascular aneurysm repair (F/BEVAR) for many years. However, their use...
Michael Jenkins
“Go for it!” Michael Jenkins urges anyone looking to start a career in medicine, highlighting that the COVID-19 pandemic has put into sharp focus...
CX Aortic Vienna: Global experts share knowledge on aortic arch and thoracoabdominal techniques
The ever-changing subject of aortic arch and thoracoabdominal treatment was addressed at CX Aortic Vienna 2021 (5–7 October, broadcast), with input from speakers and...
Vascular News’ top 10 most popular stories of April 2021
Highlights from the Charing Cross (CX) 2021 Digital Edition (19–22 April, online)—including the potential of Philips’ Fiber Optic RealShape (FORS) technology to reduce radiation...
New fenestrated Altura™ builds on standard endograft’s unique design to go a step further
The Altura™ Endograft System (Lombard Medical) is an “outstanding leap forward”, Jörg Teßarek (Lingen, Germany) tells Vascular News, while describing his experience with the...
Vascular News’ top 10 most popular stories of March 2021
Newly-published data on the benefits of a dedicated vascular limb salvage clinic, key product launches in the vascular access space, and evidence to suggest...
Study seeks to provide essential data for bridging stent use in BEVAR procedures
This advertorial is sponsored by Bentley.
There are several covered stents on the market for both fenestrated endovascular aneurysm repair (FEVAR) and branched endovascular aneurysm...
CX Aortic Vienna addresses juxtarenal issues in the challenging abdominal aneurysm neck
Expert speakers gathered online on the last day of CX Aortic Vienna to discuss juxtarenal issues in the challenging abdominal aneurysm neck, covering topics...
Important research in the aortic space highlighted in final abstract sessions
On Friday, CX Aortic Vienna livestreamed two more sessions in its “Best of CX and all abstracts” series, underscoring key research in the aortic...
CX Aortic Vienna showcases best abstracts
CX Aortic Vienna (8–11 September, virtual) hosted a “Best of CX and all abstracts” session on Wednesday, highlighting some of the more impactful and...
Inaugural joint session of the Austrian and Swiss vascular societies reaches a global audience...
Wednesday’s CX Aortic Vienna programme began with the inaugural joint session of the Austrian Society of Vascular Surgery (ÖGG) and the Swiss Society for...
CX 2020 LIVE: Surgeon-modified and custom-made endografts carve their place in juxtarenal aneurysm treatment
During the last five weeks, CX 2020 LIVE has attracted over 6,000 registrants from more than 120 countries. The topic of the 10th and final session was...
Nearly 70% of CX 2020 LIVE global aortic audience finds type II endoleak without...
A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. With registrations now well over 4,000, the pioneering...
Terumo acquires Aortica Corporation
Terumo Corporation today announced that it has decided to acquire Aortica Corporation, a US-based company dedicated to advancing the science of personalised vascular therapy.
Aortica...
The current status of new technologies and robotics in vascular surgery
In a session focused on new technologies at this year’s London Aorta meeting (10–11 October, London, UK), Celia Riga discussed the rise of robotics,...
Analysis of complex endovascular repair at single centre finds worse outcomes for women
A single-centre study of standard, fenestrated and branched endovascular aneurysm repair patients in Nürnberg, Germany, has found that outcomes for women are worse but...
CX Aortic Techniques & Technologies highlights Best of Aortic Live and Paris Endovascular Aortic...
The 2019 Charing Cross Symposium (London, UK) featured an Aortic Techniques & Technologies edited live cases session, which aimed to give delegates the opportunity...
Chimney EVAR rising: Will the technique overcome perceived shortcomings and move to the next...
In this article, Konstantinos P Donas and Frank J Criado review the evidence for endovascular aneurysm repair using the chimney technique, and consider where...
FDA approves Valiant NAVION for inclusion in physician-sponsored IDE
The Valiant NAVION stent graft system (Medtronic) has been approved by the US Food and Drug Administration (FDA) for inclusion in a physician-sponsored investigational...
New ESVS guidelines for management of AAA: What is new and how does it...
The first European Society for Vascular Surgery (ESVS) guideline on treatment of abdominal aortic aneurysm (AAA), published in the European Journal of Vascular and...
Bilateral iliac artery aneurysms associated with higher reintervention and spinal cord ischaemia rates following...
Iliac artery aneurysms—affecting up to one third of patients with complex aortic aneurysms—do not affect all-cause mortality or aneurysm-related mortality in endovascular repair of...
Watch and learn: CX Aortic Edited Cases
Tuesday’s CX Aortic Edited Cases session featured exciting and engaging standing-room only case presentations, including Andrew Holden’s (Auckland, New Zealand) first-in-man implantation of the...
Covered bridging stents in endovascular aneurysm repair
Over the past two decades, endovascular repair of abdominal aortic aneurysms (EVAR) has gained popularity. However, specified anatomic characteristics are required to achieve durable...
First two fenestrated EVAR procedures performed with the Aortica AortaFit system
Two cases have been successfully completed using the AorFit (Aortica) system to support simplified fenestrated endovascular aneurysm repair (FEVAR). The surgeries were performed by...
Physician-sponsored IDE study gains FDA approval to add more AAA devices and introduce planning...
Benjamin W Starnes expands Investigational Device Exemption study that could significantly reduce the number of abdominal aortic aneurysm patients requiring open surgery.
“Only operators and centres with the highest skill sets should be performing complex TEVAR”
With advances in technology, device availability and surgical skill sets we can expect the outcomes from endovascular repair of thoracoabdominal aortic aneurysms to continue...
PEVAR with Perclose ProGlide is non-inferior to femoral exposure and yields shorter time to...
According to results of a randomised trial published in the Journal of Vascular Surgery, compared with femoral exposure approach, the percutaneous access yielded significantly shorter times to haemostasis and procedure completion and favourable trends in blood loss, groin pain, and quality of life.
Andrew Holden
Andrew Holden, associate professor of Radiology, Auckland University School of Medicine, Auckland, New Zealand, has been involved in the investigation of several endovascular devices...
Aneurysm sac shrinkage greater with fenestrated grafts
A comparison of endovascular aneurysm repair of abdominal aortic aneurysms with suprarenal fixation devices or fenestrated devices showed no difference in terms of survival and re-intervention rates.
